ONGOING MONITORING & NEED FOR ADDITIONAL ANTIVENOM

1. Monitor the patient closely for signs of progression every 30 minutes in the initial hours of treatment until initial control of symptoms has been achieved (see Defining Initial Control by Syndrome). Detailed intervals for assessment and treatment are included in the new ACLS-style NEURO, HEMO/CYTO, and Asymptomatic algorithms.

2. After initial control, reassess for signs and symptoms of NEURO and HEMO/CYTO syndromes according to the appropriate Control Algorithm in Appendix A.